$OCUL OCULAR THERAPEUTIX, INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in OCULAR THERAPEUTIX, INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in OCULAR THERAPEUTIX, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in OCULAR THERAPEUTIX, INC for free.

CIK Number: 0001393434
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: OCUL
Company Address: 24 CROSBY DRIVE BEDFORD 01730
Phone number: 781-357-4000
Former name: I-THERAPEUTIX INC, date of change: 2007-03-15

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Market Capitalization: $171.42M
Prev close: $6.91
Average Daily Volume: 993,564
Days Low: $6.59
Year Low: $4.04
Year High: $14.50

OCULAR THERAPEUTIX, INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorOption ExerciseA13.5118,000243,18018,000
Jun 22 2021OCULOCULAR THERAPEUTIX ...PEACOCK BRUCEDirectorOption ExerciseA13.5118,000243,18018,000
Jun 22 2021OCULOCULAR THERAPEUTIX ...LINDSTROM RICHARD L MDDirectorOption ExerciseA13.5118,000243,18018,000
Jun 22 2021OCULOCULAR THERAPEUTIX ...Hong Seung SuhDirectorOption ExerciseA13.5118,000243,18018,000
Feb 19 2021OCULOCULAR THERAPEUTIX ...Goldstein Michael H.President, Ophthalm ...Option ExerciseA18.31250,0004,577,500250,000
Feb 19 2021OCULOCULAR THERAPEUTIX ...Kitchen PatriciaChief Operating Off ...Option ExerciseA18.31220,0004,028,200220,000
Feb 19 2021OCULOCULAR THERAPEUTIX ...Mattessich Antony C.President and CEOOption ExerciseA18.31455,0008,331,050455,000
Feb 17 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorSellJ0.008,604008.6 K to 0 (-100.00 %)
Feb 17 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorBuyJ0.0035,912039,5313.6 K to 39.5 K (+992.32 %)
Feb 17 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorSellJ0.00375,12100375.1 K to 0 (-100.00 %)
Feb 17 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorBuyJ0.00375,1210375,1210 to 375.1 K
Feb 17 2021OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorSellJ0.001,456,780001.5 M to 0 (-100.00 %)
Dec 08 2020OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorSellJ0.004,40308,60413 K to 8.6 K (-33.85 %)
Dec 08 2020OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorBuyJ0.003,61903,6190 to 3.6 K
Dec 08 2020OCULOCULAR THERAPEUTIX ...Warden Charles MDirectorSellJ0.0037,2080037.2 K to 0 (-100.00 %)

View all OCULAR THERAPEUTIX, INC insider transactions.